5Antin JH, Childs R, Filipovich AH, et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation [J]. Bio Blood Marrow Transplant,2001,7(9) :473-485.
6Storb RF, Champlin R, Riddell SR, et al. Non-myeloablative transplants for malignant disease. Hematology ( 2001 the American Society of Hematology Education Program Book) [M]. Washington: Fred Hutchinson Cancer Center, 2001:375-391.
7Dubovsky J, Daxberger W, Fritsch G, et al. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders:implications for timely detection of engraftment, graft failure and rejection[J]. Leukemia,1999,13(12) :2059-2069.
8De Weger RA, Tilanus MG, Scheidel KC, et al. Monitoring of residual disease and guided donor leucocyte infusion after allogeneic bone marrow transplantation by chimaerism analysis with short tandem repeats[J]. Br J Haematol, 2000,110(3): 647-653.
9Novitzky N, Rubinstein R, Hallett JM, et ah Bone marrow transplantation depleted of T cells followed by repletion with incremental doses of donor lymphoeytes for relapsing patients with chronic myeloid leukemia: a therapeutic strategy [ J ]. Transplantation, 2000,69 (7): 1358-1363.
10Huang CA,Fuchimoto Y,Scheirer DR,et al.Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large animal model.J Clin Inv,2000; 105:173 -181.
